FindMyKOL
Clinical trialNCT01912534CompletedPhase 2Interventional

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

SponsorCarelon ResearchEnrollment211Hypertrophic Cardiomyopathy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this trial is to determine whether treatment with valsartan will have beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that reflect myocardial structure, function and biochemistry.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Toronto General Hospital

    Toronto, Ontario, Canada

  • Toronto Sick Kids

    Toronto, Ontario, Canada

United States
  • Stanford University

    Stanford, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • Children'S Hospital Boston

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Washington University School Medicine

    St Louis, Missouri, United States

  • Cinncinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2014
Primary completion
31 Jul 2019
Completion
31 Jul 2019
Last update posted
11 Jan 2021
Registered enrollment
211
Registry id
NCT01912534

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.